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Although transcriptome analysis can uncover the
molecular changes that occur during induced reprog-
ramming, the functional requirements for a given
factor during stepwise cell-fate transitions are left
unclear. Here, we used a genome-wide RNAi screen
and performed integrated transcriptome analysis to
identify key genes and cellular events required at the
transition steps in reprogramming. Genes associated
with cell signaling pathways (e.g., Itpr1, Itpr2, and
Pdia3) constitute the major regulatory networks
before cells acquire pluripotency. Activation of a spe-
cific gene set (e.g., Utf1 or Tdgf1) is important for
mature inducedpluripotent stemcell formation. Strik-
ingly, a major proportion of RNAi targets (53% to
70%) includes genes whose expression levels are
unchanged during reprogramming. Among these
non-differentially expressed genes, Dmbx1, Hnf4g,
Nobox, and Asb4 are important, whereas Nfe2,
Cdkn2aip, Msx3, Dbx1, Lzts1, Gtf2i, and Ankrd22 are
roadblocks to reprogramming. Together, our results
provide a wealth of information about gene functions
required at transition steps during reprogramming.
INTRODUCTION
Somatic reprogramming to pluripotent status can be achieved
by introducing a limited number of transcription factors, in-
cluding Oct4, Sox2, Klf4, and c-Myc (OSKM); Nanog; and
Lin28 (Takahashi et al., 2007; Takahashi and Yamanaka, 2006;
Yu et al., 2007). Induced pluripotent stem cells (iPSCs) strongly
resemble embryonic stem cells (ESCs) and hold promise for
customized regenerativemedicine (Grskovic et al., 2011; Jopling
et al., 2011; Robinton and Daley, 2012; Tiscornia et al., 2011; Wu
and Hochedlinger, 2011).
One of the primary obstacles to the successful application of
iPSCs for medical purposes is their low reprogramming effi-
ciency. Significant effort has been devoted to enhancing inducedreprogramming efficiency, including approaches focusing on the
use of mRNA (Warren et al., 2010), small molecules (Ichida et al.,
2009; Li and Rana, 2012; Maherali and Hochedlinger, 2009;
Nichols et al., 2009; Silva et al., 2008; Yang et al., 2011b; Ying
et al., 2008; Zhu et al., 2011), and microRNAs (Choi et al.,
2011; Judson et al., 2009; Kim et al., 2011; Li and He, 2012; Li
et al., 2011; Liao et al., 2011; Lipchina et al., 2011; Melton
et al., 2010; Pfaff et al., 2011; Subramanyam et al., 2011; Yang
and Rana, 2013; Yang et al., 2011a). However, detailed func-
tional insight into the molecular basis of reprogramming is still
lacking.
It has been shown that a few markers, including Thy1, alkaline
phosphatase, and SSEA1, can be used to identify transformed
cells through the process of induced reprogramming, whereas
ESC-specific genes (Nanog,Oct4, and Tert) are activated at later
stages (Brambrink et al., 2008; Stadtfeld et al., 2008). More
recent research further suggests that induced reprogramming
is a stepwise event, comprising initial, mature, and stabilization
stages (Samavarchi-Tehrani et al., 2010). Several key cellular
events have been observed during reprogramming, such as
mesenchymal-to-epithelial transition (Li et al., 2010; Sama-
varchi-Tehrani et al., 2010) and cell-cycle modulation (Banito
et al., 2009; Hong et al., 2009; Kawamura et al., 2009; Li et al.,
2009; Mario´n et al., 2009; Utikal et al., 2009). Furthermore, the
epigenome is reset upon induced reprogramming (Koche et al.,
2011; Maherali et al., 2007), and epigenetic regulators play
important roles in the reprogramming process (Onder et al.,
2012). The cooperation of OSKM has also been considered a
factor critical to efficient reprogramming (Carey et al., 2011;
Soufi et al., 2012; Sridharan et al., 2009). Many ESC-specific
genes (e.g., Esrrb, Sall4, and Nanog) are shown to be markers
for defining reprogramming stages (Brambrink et al., 2008;
Stadtfeld et al., 2008). However, functional molecular networks
required for cell-fate transitions are not clear during the reprog-
ramming process.
Here, by isolating pure populations of cells during various
stages of reprogramming and combining this with a genome-
wide RNAi screen and transcriptome analysis, we were able to
discover key genes and cellular events involved in the transitions
associated with the reprogramming process. Moreover, we
functionally identified the critical genes required to modulateCell Reports 8, 327–337, July 24, 2014 ª2014 The Authors 327
A B
C
Figure 1. RNAi Screen Identifies Key Modu-
lators of Induced Reprogramming.
(A) RNAi screening strategy. Thy1+/DsRed+ MEFs
were transduced with a library of 57,000 shRNAs
and OSKM and sorted into four populations based
on Thy1, SSEA-1, and DsRed marker combina-
tions. Integrated shRNAs were amplified from
genomic DNA isolated from those populations and
sequenced.
(B) Heat map showing mRNA expression profiles
during reprogramming. RNA extracted from cell
populations was analyzed by microarray. Data
were processed and visualized using Cluster and
Java TreeView, respectively. Gene expression
patterns are clustered into groups defined as I–V.
Duplicate samples are designated as nos. 1 and 2.
Fold changes in mRNA level relative to MEFs in five
expression groups are represented in log2 scale.
(C) Heat map showing enriched shRNA targets in
sorted populations along the reprogramming pro-
cess. Targets identified by shRNA reads were
clustered by using Cluster 3.0 and visualized with
Java TreeView. Letters A– D mark four distinct
clusters. GO analysis was performed using IPA.
Reads of shRNA-identified targets are shown in
log10 scale.
See also Figures S1 and S2.the reprogramming process. We further validated a series of
genes that either block or enhance the reprogramming process.
We found that non-differentially expressed genes play important
roles in modulating cell-fate transitions during reprogramming.
RESULTS
Experimental Strategy for Genome-wide RNAi Screen in
Induced Reprogramming
To elucidate the molecular requirements of induced reprogram-
ming, we conducted loss-of-function assays during the reprog-
ramming process. We used a genome-wide RNAi screen and
transcriptome analysis upon induced reprogramming to func-
tionally validate the roles of key regulators in a stepwise manner
(Figure 1A). Thismethod allowed us to identify the cell-fate deter-
minants in reprogramming without making any assumptions
about function based on gene expression (Figures 1A and
S1A–S1F).
First, we established a set of markers to isolate desired cell
populations from a heterogeneous pool of reprogrammed cells328 Cell Reports 8, 327–337, July 24, 2014 ª2014 The Authorsby OSKM reprogramming factors. Thy1
is highly expressed in mouse embryonic
fibroblasts (MEFs) and subsequently di-
minishes during the progression of re-
programming (day 3– 5 post induced
reprogramming), whereas SSEA1 is ab-
sent in MEFs but gradually increases at
day 7 upon induced reprogramming
(Brambrink et al., 2008; Stadtfeld et al.,
2008). Therefore, Thy1 can serve as an
early stage marker and SSEA1 can serveas a middle- to late-stage marker for assessing reprogramming
progress. In addition, it has been shown that retroviral se-
quences are repressed in ESCs (Macfarlan et al., 2011; Wolf
and Goff, 2007); thus, we used the DsRed gene driven by retro-
viral long terminal repeats (pMX-DsRed) as a marker to differen-
tiate incomplete reprogrammed cells from mature ones. We
used these three markers to define four different cell-fate stages
in reprogramming: Thy1+/SSEA1 for the initial stage, Thy1/
SSEA1 for the transition stage, SSEA1+/DsRed+ for the prede-
termined (early reprogrammed) stage, and SSEA1+/DsRed for
the mature reprogrammed stage (Figure 1A). As starting mate-
rial, we isolated high-purity (98%) MEFs expressing Thy1 and
DsRed (Figures S1B and S1E) by using fluorescence-activated
cell sorting (FACS). Reprogramming was initiated by transducing
these cells with retroviruses expressing OSKM plus lentiviruses
containing a whole-genome small hairpin RNA (shRNA) library
(Figures 1A, S1C, and S1D).
We sorted cells 14 days later (Figure S1C), when reprogram-
ming is reportedly complete in MEFs and the transcriptome
relatively defined (Hanna et al., 2009; Yamanaka, 2009). Four
high-purity cell populations (95%–99%purity) were isolated (Fig-
ure S1F) representing stages defined above (Figure 1A). Surpris-
ingly, most cells (>80%) were at the transition (Thy1/SSEA1)
stage, whereas only 1%–2.5% reached SSEA1+ stages (Fig-
ure S1G and Table S1), suggesting that re-establishing pluripo-
tency networks is the rate-limiting step in reprogramming. Four
sorted cell populations were confirmed to properly represent
the normal reprogramming process by examining ESC-specific
regulators (e.g., Esrrb, Nanog, Lin28a, and Sall4) and mesen-
chymal-to-epithelial transition regulators (e.g., Cdh1, Ocln,
Krt8, Snai1, Zeb1/2, and Ncam1) (Figure S1H).
To define the transcriptome in sorted populations, we used
k-means clustering to profile gene expression patterns and
identified five groups (I–V) of mRNAs (Figure 1B and Table S1).
We defined groups I, II, and III as ‘‘differentially expressed’’
genes and groups IV and V as non-differentially expressed or
unchanged genes during the reprogramming process. Gene
ontology (GO) analysis showed that genes associated with em-
bryonic development, cell cycle, and cell death were significantly
overrepresented in groups I– III, and that genes associated with
cellular function and maintenance, molecular transport, and
metabolism were significantly enriched in groups IV and V (Fig-
ures S1I and S1J and Table S1). As expected, this finding dem-
onstrates that differentially expressed genes (groups I– III) are
highly related to ESC function and that non-differentially ex-
pressed genes (groups IV and V) are related to basal cellular
functions.
Identifying Key Transcriptome Hallmarks in Each Cell-
Fate Transition during Reprogramming
It remains poorly understood whichmolecular hurdles are critical
to overcome for cells to make a transition from initial to mature
stages of reprogramming. To address this, we examined tran-
scriptome differences in each cell-fate transition. A majority of
the transcriptome changes occurred at the MEF-to-Thy1+/
SSEA1 (1,373 genes) and Thy1+/SSEA1-to-Thy1/SSEA1
(1,387 genes) transitions (Figures S2A and S2B), whereas fewer
occurred in later Thy1/SSEA1-to-SSEA1+/DsRed+ (312
genes) and SSEA1+/DsRed+-to-SSEA1+/DsRed (283 genes)
transitions. These results showed that a massive transcriptome
reconstruction primarily occurs in the early stages before cells
obtain an SSEA1+ marker, which pushes committed cell popula-
tions toward pluripotency (Figure S2F). Our data suggest that the
first two transitions may be the cell-fate-reorganizing phases,
comprising the respond-to-reprogramming-stress step and
the deconstructing-of-somatic-networks step. Following these
steps, the next two transitions are cell-fate-committing phases,
wherein ESC-specific regulatory networks are acquired for
attaining pluripotent status in the context of dominant OSKM
expression (Figures S2D–S2F).
Stage-specific genes are identified in each transition (e.g., Lyz,
Lyzs, Mrc1, Slc38a5, Laptm5, Ms4a6d, Nanog, Sall4, Esrrb,
Dppa4, Dppa5a, Dnmt3b, and Dnmt3l) (Figures S2B). Cellular
functions critical for transition steps of reprogramming were
identified by GO analysis (Figure S2C), showing that modulating
somatic cell functions are required in the initial stages and that
genes associated with ESC pluripotency are highly regulated in
the subsequent stages.GO analysis of the differentially expressed genes at each tran-
sition suggests that a number of canonical pathways, including
hepatic fibrosis, stellate cell adhesion, matrix metalloproteases,
and adhesion and diapedesis, are important for modulating the
fibroblast property (Figure S2C) before cells reach the next two
SSEA1+ stages. Consistently, key molecules associated with
fibrotic properties, Lyz and Lyzs, are among the top 20 differen-
tiated genes at the first two transitions (Figure S2B). This is
consistent with previous findings that an early step in reprogram-
ming is the destruction of somatic regulatory networks (Bram-
brink et al., 2008; Stadtfeld et al., 2008). Genes involved in
ESC pluripotency are activated starting at the Thy1/SSEA1-
to-SSEA1+/DsRed+ transition (Figure S2C). Additional ESC-
specific networks are activated in the final transition from the
SSEA1+/DsRed+ to SSEA1+/DsRed stages (Figure S2C). See
Table S1 for the detailed information about differentially ex-
pressed genes between transitions in reprogramming.
Our data indicate that to reach the ‘‘early reprogrammed’’
SSEA1+/DsRed+ stage, it is important to activate many of the
key players involved in the ESC core circuitry, including Nanog,
Sall4, Esrrb, Dppa4, Dppa5a, Dnmt3b, and Dnmt3l (Figure S2D)
(Buganim et al., 2012; Hansson et al., 2012; Polo et al., 2012).
Our cell sorting data (Figure S1G) also suggested that the transi-
tion of Thy1-to-SSEA1+ is the rate-limiting step, because a
majority (80%) of transformed cells were ‘‘trapped’’ in the
Thy1/SSEA1 stage, and the initial induction of several ESC-
specific factors (e.g., Nanog, Sall4, and Esrrb) is required to
overcome this threshold. For predetermined cells (SSEA1+/
DsRed+), in order to progress to a mature reprogrammed status
(SSEA1+/DsRed), those molecules are further induced to a
higher expression level (Figure 2E), possibly to acquire a com-
plete pluripotent state. Furthermore, when cells proceed from
the SSEA1+/DsRed+ to SSEA1+/DsRed stages (Figure 2F),
more extensive interactions of ESC core regulators are estab-
lished, including Utf1, Tdgf1, Gsc, Fgf10, T, Chrd, Dppa3,
Fgf17, Eomes, and Foxa2, indicating that the final step of reprog-
ramming is to reinforce the regulatory pathways in ESC core
circuitry.
Discovering a Variety of Sources for Induced
Reprogramming and Cell-Fate Manipulation
The choice of somatic cells contributes significantly to reprog-
ramming efficiency (Gonza´lez et al., 2011). Therefore, we
reasoned that our sorted cells might resemble certain tissue
types, which could be better and alternative resources for
induced reprogramming. To test this idea, we compared tran-
scriptome profiles from the reprogramming process with those
from various tissue types in vivo (Kupershmidt et al., 2010).
This algorithm was designed to find correlations between genes
of interest (queries) and normalized gene expression across all
available tissues, cell types, cell lines, and stem cells in a library;
this is accomplished by calculating mRNA expression profiles
with a positive or negative correlation. We found that the
transcriptome of SSEA1+/DsRed cells most resembled that of
cells derived from the visual (choriocapillaris endothelium)
(p value < 1 3 10153), urogenital (p value < 1 3 10130), and
immune (p value < 1 3 1040) systems (Figure S2G). Interest-
ingly, Thy1/SSEA1 cells have low significant correlationsCell Reports 8, 327–337, July 24, 2014 ª2014 The Authors 329
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Figure 2. Key Regulatory Hubs Are Identi-
fied in Each Stage during Induced Reprog-
ramming
(A) Overrepresentative canonical pathways iden-
tified in reprogramming. Qualified hits (shRNA
reads > 1.5 in log10 scale) were analyzed using IPA.
Only the most significant pathways (p value < 0.01)
are shown here. The size of each circle is propor-
tional to the p value to represent the significance.
The cell stages are shown inside the box on the
left.
(B) Key molecular and cellular functions identi-
fied by shRNA screening. Qualified hits (shRNA
reads > 1.5 in log10 scale) were analyzed using IPA.
Cluster identifications are shown at left. p values
are based on Fisher’s exact test.
See also Figure S3.
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(p value < 1 3 109 to 1 3 1017) with any tissue type (Fig-
ure S2G), suggesting a high degree of heterogeneity of cell con-
tents in this status (Thy1/SSEA1). Thy1/SSEA1 statusmight
serve as the cell-fate-decisive stage prior to commitment of cell
types, because of highly heterogeneous cell types with low
mRNA expression correlations to well-defined tissue types.
Finally, we showed that cells from the visual system (choriocapil-
laris endothelium) and immune systemmight serve as alternative
resources for efficient reprogramming due to high transcrip-
tome-correlation parameters.
Cell Signaling Pathways Are Determinative Factors in
the ‘‘Prime’’ Stage before Cell-Fate Commitment
We reasoned that essential genes of cell-fate transitions should
be identified in specific sorted cells in reprogramming by a
genome-wide RNAi screen (Figure 1A). To obtain enriched
shRNAs integrated in specific cell stages, we isolated genomic
DNA from sorted cells and sequenced it with high-throughput
sequencing. Next, to find shRNA targets enriched specifically
in each cell population, we performed k-means clustering for
identified reads from sorted populations based on the relative
enrichment in different cell populations. We obtained four
stage-specific gene clusters (A, B, C, and D) enriched in each
population (Figure 1C). In cluster A, 829 genes are specifically
targeted (Thy1+/SSEA1); 784 genes are in cluster B (Thy1/
SSEA1); 206 genes are in cluster C (SSEA1+/DsRed+); and
898 genes are in cluster D (SSEA1+/DsRed). Grouped into
cluster E are 1,972 genes that are not categorized (Table S2).
Surprisingly, we got the highest number of target genes (898
out of 2,717 identified genes) from the population with the lowest
cell number (SSEA1+/DsRed; 0.2%–0.4% of transduced
cells; see Table S1), suggesting that our RNAi screen indeed
identified genes with relevant functions to reprogramming
regardless of the cell number in each sorted population.
To understand the biological functions of shRNA-identified
genes, we conducted a meta-analysis of enriched-shRNA hits
using Ingenuity Pathway Analysis (IPA) software (http://www.
ingenuity.com/). We identified several canonical pathways,
which were significantly targeted to influence the transitions
between each stage of reprogramming (Figure 2A). Pla2g10,
Pla2g12b, Npr1,Gucy1a3, and Plch2 (spermmotility and synap-
tic long-term depression pathways) are required for the dediffer-
entiation of fibroblasts, because cells were ‘‘stuck’’ in the initial
stage in which these genes are depleted. Strikingly, various
signaling pathways are highly overrepresentative in the second
stage of reprogramming (Thy1/SSEA1). We found a number
of known reprogramming regulators including PI3K and Akt
(CREB signaling pathway) (Yu et al., 2014). Additionally, we
found that Itpr1, Itpr2, Pdia3, and Camk4 are common compo-
nents linking several signaling pathways (Figure 2A and Table
S2), such as nitric oxide, neuropathic pain, CREB, and EGF
signaling pathways. This significant enrichment of signaling
pathways in this cell population indicates that this stage
(Thy1/SSEA1) might be the ‘‘prime’’ stage, requiring a signifi-
cant amount of sensing and signaling to define the specific cell
fate in the next step of reprogramming.
In Figure 2A, Egf, Flt1, Il1rl1, and Ly96 (hepatic fibrosis
pathway) are identified in the precommitment stage (SSEA1+/DsRed+), suggesting that it is critical to modulate cell-to-cell
signaling and interaction so that transformed cells are able to
overcome the rate-limiting step from the ‘‘prime’’ stage. To reach
the last stage of reprogramming (SSEA1+/DsRed), depletion of
Cfl1, Mprip, and Ppp1r12 (regulation of actin-based motility by
Rho pathway) benefits the maturation process of reprogrammed
cells (Figure 2A and Table S2), indicating that transforming the
cytoskeleton is an important step for building ESC-like cellular
organization (Sakurai et al., 2014).
Notably, most genes associated with key networks were tar-
geted by shRNAs in the same stage (Figures S3A and S3B and
Table S2), including cell signaling, cellular assembly, gene
expression control, development, protein synthesis, cell cycle,
cell programmed death, and metabolism. These highly targeted
networks may serve as central hubs for determining the transi-
tion of cell identities.
As previously reported, genes associated with cell cycle or cell
death and survival (Banito et al., 2009; Hong et al., 2009; Kawa-
mura et al., 2009; Li et al., 2009; Mario´n et al., 2009; Utikal et al.,
2009) are also identified in our RNAi screen (Figure 2B and Table
S2) and act as checkpoints in the initial or final stage (Figure 2B).
Surprisingly, we found that a significant proportion of essential
networks and functions are also responsible for maintaining
basal cellular functions, such as cell signaling, metabolism, cell
morphology, cellular assembly, and organization (Figure 2B
and Table S2). This finding prompted us to further investigate
whethermany important regulators in reprogramming are always
tissue-specifically expressed in ESCs or iPSCs and whether
some of those regulators might be genes whose expression
does not change very significantly during the reprogramming
process.
Non-Differentially Expressed Genes Play Important
Roles in Modulating Cell-Fate Transitions during
Reprogramming
To examine whether the non-differentially expressed genes play
any roles in cell-fate decision during reprogramming, we per-
formed an in-depth analysis by integrating data sets generated
from RNAi screen and transcriptome analysis (Figure S3C). First,
we asked whether we could identify specific mRNA expression
patterns from genes targeted by shRNAs. To do so we used
target lists developed via RNAi screen (Figure 1C) as seeds
(queries) for identifying expression profiles from transcriptome
analysis (Figure 1B). We defined mRNA profiles corresponding
to four clusters of shRNA-identified targets. However, we did
not observe enrichment of specific gene expression patterns
among these groups (Figures 3A and 3B), indicating that genes
with stage-specific functions in reprogramming may not show
corresponding changes in mRNA expression levels. Strikingly,
a major proportion of identified shRNA targets (53%– 70%)
are genes whose expression did not change during reprogram-
ming (as indicated by the yellow rectangles in Figure 3A),
showing that these non-differentially expressed genes are
indeed important for reprogramming transitions.
Second, we asked whether mRNA expression profiles could
predict cell-fate-specific functions in reprogramming. To do so,
we took the approach described above but instead used gene
lists from the transcriptome analysis (Figure 1B) as queries toCell Reports 8, 327–337, July 24, 2014 ª2014 The Authors 331
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Figure 3. Revealing Non-Differentially ExpressedGenesRegulating Cell-Fate Transitions in Reprogramming by Integrated shRNAScreening
and Transcriptome Profiling
In-depth analysis performed by integrating data sets generated from RNAi screen and transcriptome analysis. A scheme showing the strategy for performing
integrative analysis of shRNA screening and transcriptome data is shown in Figure S3C.
(A) Heat map illustrating mRNA expression profile of genes identified from shRNA (groups A–D) library screening in Figure 1C. Only shRNA target genes having a
read cutoff >1.5 (log10 scale) are analyzed. shRNA target genes were used as seeds for identifying mRNA expression profiles from transcriptome analysis
presented in Figure 1B. mRNA profiles corresponding to four clusters of shRNA-identified targets were defined. From left to right, mRNA expression trends are
shown from initiation maturation stages of reprogramming (upper right rectangle), and the number of qualified targets is listed in the lower right rectangle. Non-
differentially expressed genes are highlighted within the yellow rectangle in each group. Fold changes in expression relative to MEFs are shown in log2 scale.
(B) Proportion of three different expression patterns corresponding to shRNA-identified genes shown in Figure 3A. Genes identified in Figure 1B were shown as a
percentage corresponding to each group of shRNAs (groups A–D) in Figure 1C. Blue indicates downregulated genes, red indicates upregulated genes, and green
indicates minor expression changes. The relative proportion of each expression pattern is indicated in three different colors.
(C) Heat map illustrating shRNA reads of unique expression pattern groups shown in Figure 1B. Reads from the shRNA screen were analyzed using gene lists for
each group from Figure 1B (group I–V). Only qualified targets (shRNA reads > 1.5 in log10 scale) are analyzed. Genes from each cluster (I–V) were used as seed to
identify shRNA enrichment. From left to right, shRNA reads were presented from initiation stage to maturation stages as indicated above. The number of qualified
genes frommRNAmicroarray analysis and shRNA library screening is listed on right. Genes identified as non-enriched-shRNA targets are highlightedwith orange
rectangles (described as group E in Figure 3D and in Table S2). Non-differentially expressed genes with cell-fate modulation functions are highlighted within the
blue rectangle in groups IV and V. Reads of the shRNA library are shown in log10 scale.
(D) Proportion of enriched shRNA-identified targets corresponding to clusters in transcriptome analysis shown in Figure 3C. shRNA-identified genes in Figure 1C
were shown as a percentage corresponding to expression groups clustered in Figure 1B. Enriched shRNA targets are indicated in the different colors
listed above.
See also Figure S3.find specific patterns of enriched shRNA targets. Surprisingly,
the majority of the genes in group I show no specific enrichments
in corresponding shRNA targets during reprogramming (as indi-
cated by the orange rectangles in Figure 3C), suggesting that
50% (238 out of 476 genes) of ESC-enriched genes have little
function in the reprogramming process (Figure 3D). Importantly,
group I, II, and III genes with functional influence in reprogram-
ming are present across various sorted cell populations, rather332 Cell Reports 8, 327–337, July 24, 2014 ª2014 The Authorsthan only a certain stage (Figures 3C and 3D), indicating that spe-
cific roles of tissue-enriched genes couldn’t be comprehensively
revealed by expression profiling in reprogramming.
We found that 362 out of 566 genes (64%) and 668 out of
1,365 genes (49%) in groups IV and V, respectively (blue rect-
angles in Figure 3C), are specifically identified by RNAi screen
during various stages of reprogramming (Figures 3C and 3D),
showing that non-differentially expressed genes in groups IV
and V significantly contribute to cell-fate transitions. As ex-
pected, a large proportion of matched genes (36% and 51%,
respectively) in mRNA groups IV and V are clustered in non-
enriched-shRNA group E (as indicated by the orange rectangle
in Figures 3C and 3D). For complete information about RNAi-
identified targets, see Table S2. In summary, we found that
non-differentially expressed genes in groups IV and V indeed
play important roles in modulating the reprogramming progress.
HighDiscovery Rate in Identifying Positive Regulators or
Barrier Genes for Reprogramming
Next, we performed validation experiments on target genes
identified in the RNAi screen and bioinformatics analyses pre-
sented above. To assess shRNA-identified targets, we selected
stage-specifically enriched targets (reads with log10 value > 1.5;
Table S2) from the initial and mature-reprogrammed stages (Fig-
ures 1C, S3A, and S3B). To examine targets from the transcrip-
tome analysis, we selected genes highly induced in group I
(Figure 1B and Table S1). Most selected genes from both ana-
lyses encoded proteins involved in transcriptional regulation.
To determine whether shRNA-identified genes in specific
populations can promote or comprise reprogramming, we per-
formed siRNA-mediated knockdown of specific genes upon
induced reprogramming. We first picked genes selectively
targeted by shRNAs in the Thy1+/SSEA1 cell population
(group A) (Figure S3A and Table S2), reasoning that these genes
might be positive regulators for reprogramming. To assess re-
programming efficiency of cells with small interfering RNA
(siRNA)-mediated depletion, we quantified Oct4-GFP-positive
colonies 2 weeks after virus transduction. Of six selected
genes, depletion of five (83%; Dmbx1, Gsc, Med21, Hnf4g,
and Nobox) significantly reduced reprogramming efficiency
(p value < 0.05) (Figure 4A). The knockdown level of target genes
was verified by quantitative RT-PCR (qRT-PCR) (Figure S5A). To
further independently validate the observed phenotype of these
genes through an alternative approach, we employed shRNA-
mediated knockdown of these genes. Stronger reduction of
iPSC generation was observed with shRNA-mediated depletion
of Dmbx1, Gsc, Med21, Hnf4g, Nobox, and Asb4 (Figure S4A).
Additional genes from shRNA group A (Psmd9 and Mef2c)
were also tested to show the same phenotype of iPSC reduction
(Figure S4A). The knockdown level of target genes was verified
by qRT-PCR (Figure S5B). Most importantly, 4 out of 8 tested
positive regulators (Dmbx1, Hnf4g, Nobox, and Asb4; Fig-
ure S4A) show no expression changes during reprogramming
(Figure 4D), supporting our hypothesis that non-differentially
expressed genes indeed contribute to cell-fate decision. Over-
expression of a non-differentially expressed gene (Nobox) is suf-
ficient to boost reprogramming efficiency by 2-fold, compared
with DsRed control (Figures S4G and S4H).
Using a similar approach, we examined the effect of genes
(group D) selectively targeted by shRNAs in mature reprog-
rammed cells (SSEA1+/DsRed), assuming that they might
represent reprogramming barriers (Figure S3B and Table S2).
Following knockdown of 16 candidates at early stages of reprog-
ramming (including Tfdp1, Gtf2e1, Nfe2, Foxn3, Erf, Cdkn2aip,
Msx3, Ssbp3, Dbx1, Hoxd4, Lzts1, Arx, Hoxd12, Gtf2i, Ankrd22,
and Hoxc10), depletion of 12 (75%) improved reprogrammingefficiency by at least 2-fold (dotted line, Figure 4B) compared
with controls. The barrier roles of several gene targets (Tfdp1,
Cdkn2aip, Msx3, Ssbp3, Dbx1, and Ankrd22) in reprogramming
were further confirmed by shRNA knockdown (Figure S4B).
The mRNA levels of genes targeted by siRNAs or shRNAs was
verified by qRT-PCR (Figures S5C and S5D). Strikingly, 8 out
of 16 tested barrier genes (Nfe2, Cdkn2aip, Msx3, Dbx1, Lzts1,
Arx, Gtf2i, and Ankrd22) showed no expression changes during
reprogramming (Figure 4E), again supporting our findings that
many non-differentially expressed genes act as important mod-
ulators for cell-fate transition. To further examine the roles of
these non-differentially expressed genes, we picked several
genes with no expression changes (mRNA groups IV and V)
from each shRNA-enriched group (A to D) for testing reprogram-
ming efficiency (Table S2). We found that genes (Gja3, Olfr1271,
Fkbp11, Mdm1, Myo15, and Gucy2g) identified in early or pre-
committed cell populations (shRNA groups A– C) are required
for efficient reprogramming, whereas genes identified in shRNA
group D (Lasp1 and Hspa8) are obstacles for reprogramming.
The knockdown efficiency of select genes targeted by shRNAs
was verified by qRT-PCR (Figure S5E). For detailed information
about non-differentially expressed genes with cell-fate modula-
tion functions, see Table S2.
Next, we tested the function of barrier genes by overexpress-
ing them during reprogramming with OSKM. Expression of these
factors was confirmed by western blotting or immunofluores-
cence (Figures S3D and S3E). Overexpression of barrier genes
compromised reprogramming efficiency by 40%– 80% com-
pared with DsRed controls (Figure 4C), demonstrating that tar-
gets identified by our RNAi screen and bioinformatics analyses
indeed function as barriers to reprogramming. We further exam-
ined the roles of target genes identified in shRNA groups A and B
in reprogramming. During reprogramming, we expressed Mef2c
(shRNA-identified group A) and Pdia3 (key component in the
signaling pathway in shRNA-identified group B; Figure 2A) and
observed that iPSC generation is greatly enhanced by 4- to
6-fold compared with DsRed control (Figures S4G and S4H).
To test the function of genes identified by the transcriptome
analysis, we asked whether genes highly induced during reprog-
ramming (group I) contribute to maintaining ESC identity. Among
group I genes, we analyzed the effect of a panel of transcription
factors with little-known function on ESC self-renewal (Fig-
ure S3F). In addition, we determined the role of positive regula-
tors (Figures 4A and S4A) in ESC identity. To do so, we treated
Oct4-EGFP ESCs with specific siRNAs and assessed ESC
self-renewal 4 days later using flow cytometry to detect an
enhanced GFP (EGFP) signal. In 16 of 64 tested genes (25%),
the Oct4-EGFP signal was significantly reduced (Z score > 2)
(Figure S3F). In addition to the known regulatory factors of
ESCs or iPSCs (Nanog and Oct4), we discovered several key
players that maintain ESC identity, such as Asb4, Dmbx1,
Gbx2, Gsc, Hnf4g, Klf5, L3mbtl2, Med21, Mef2c, Nobox,
Pcgf6, Phox2a, Tcf15, and Trim28. In summary, our genome-
wide RNAi screen with sorted cell populations efficiently identi-
fied key regulators, serving either positive roles (e.g., Dmbx1,
Gsc, Med21, Hnf4g, Mef2c, and Psmd9) or barrier roles (e.g.,
Nfe2, Cdkn2aip, Msx3, Dbx1, Lzts1, Arx, Gtf2i, and Ankrd22)
during reprogramming. We also identified several additionalCell Reports 8, 327–337, July 24, 2014 ª2014 The Authors 333
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Figure 4. Functional Validation Shows a High Discovery Rate in Identifying Positive Regulators or Barrier Genes for Reprogramming
(A) Bar graph showing reprogramming efficiency following siRNA knockdown of positive regulators. Indicated siRNAs plus OSKM were introduced into 43 104
cells of Oct4-EGFP MEFs, and colonies were scored for EGFP positivity. Oct4 knockdown served as positive control. Nontargeting siRNA served as negative
control (Control). Error bars represent SEM, nS 3. The solid line marks the control value, and the dashed line shows the cutoff value based onOct4 knockdown.
Student’s t test, *p < 0.05; **p < 0.005.
(B) Bar graph showingMEF reprogramming efficiency following barrier gene depletion. Reprogramming efficiency was assayed as in (A). Trp53 (p53) knockdown
served as positive control. Nontargeting siRNA served as negative control (Control). Error bars represent SEM, nS 3. The solid line marks the control value, and
the dashed line marks the cutoff value of 2-fold changes. Student’s t test, *p < 0.05; **p < 0.005; ***p < 0.0005; ****p < 0.00005.
(C) Fold changes in MEF reprogramming efficiency following barrier gene overexpression. Transgenes plus OSKM were introduced into 4 3 104 cells of Oct4-
EGFP MEFs and assayed as described above. Reprogramming efficiency was calculated following normalization to DsRed control. Error bars represent SEM,
nS 3. Student’s t test, *p < 0.05 and ****p < 0.00005.
(D) Expression profiling of genes potentially essential to reprogramming. Expression of specific genes was examined during reprogramming. MEFs and ESCs
serve as controls for two determined cell types. Replicates are designated nos. 1 and 2. Non-differentially expressed genes are highlighted in red boldface text.
Fold-change values are presented on a log2 scale.
(E) Expression profiling for putative barrier genes. Expression of specific genes was analyzed as in (D). Non-differentially expressed genes are highlighted in red
boldface text.
See also Figures S3, S4, and S5.regulators (e.g., Asb4, Gbx2, Gsc, Hnf4g, and Mef2c) that play
important functions in maintaining ESC identities. Collectively,
our genome-wide RNAi screen has identified numerous regula-
tors of reprogramming (Figure S6), which lays the comprehen-
sive foundation of molecular requirements and regulatory
networks during reprogramming.334 Cell Reports 8, 327–337, July 24, 2014 ª2014 The AuthorsDISCUSSION
In this study, we sought to define the molecular signatures of
stepwise induced reprogramming by functional genomics.
We dissected the regulatory networks, employing a pooled
genome-wide shRNA library in a stepwise manner by applying
FACS to isolate groups of distinct cell populations representing
four critical steps from initiation to maturation of induced reprog-
ramming. Results of our RNAi screen provided unbiased func-
tional insight into essential factors during each step of the
reprogramming progress. The high validation rate of identified
genes in this study suggests that our strategy is highly valuable
for the discovery of key regulatory molecules and networks in
the reprogramming process.
We found that the majority of transformed cells are ‘‘trapped’’
in the transition stage (Thy1/SSEA1), with divergent transcrip-
tomes showing correlations to various tissue types. This finding
implies that cells are reset at this ‘‘prime’’ phase where cells
might have the potential to adopt distinct cell fates until the
‘‘right’’ molecular networks are rebuilt. This notion is supported
by recent studies (Hansson et al., 2012; Polo et al., 2012;
Shu et al., 2013) showing that readministration of OSKM or
lineage specifiers into those transitioning cells drove more cells
into pluripotent or other desired states. The potential diversity
of cell fates at the Thy1/SSEA1 stage is usually ignored,
probably because the only desired cell type here is pluripotent
stem cells. However, these ‘‘transitioning’’ cells with high plas-
ticity may provide a good starting point for various cell-fate
interconversions.
A recent study using a similar approach (Polo et al., 2012) has
shown that a majority of cells that even had a prolonged culture
after sorting did not greatly change their identities. Our transcrip-
tome analysis is consistent with previous studies (Brambrink
et al., 2008; Buganim et al., 2012; Polo et al., 2012) delineating
the stepwise marker genes during the reprogramming. Despite
our efforts to obtain a relatively ‘‘terminated’’ cell fate of trans-
formed cells in each population at the end of a 2-week reprog-
ramming course, it is possible that there are cells present at
different levels and stages of latencies in reprogramming, mak-
ing it difficult to completely rule out the heterogeneity issues in
our analysis.
In this study, we used DsRed expression as an indicator of
‘‘mature reprogrammed’’ cells. Although Nanog, Sall4, and
Essrrb genes have been slightly activated in SSEA1+/DsRed+
cells, these genes are further induced to a higher expression
level (Table S1), and ESC-like epigenetic regulation is resotred
to silence the retroviral gene (pMX-DsRed) only in SSEA1+/
DsRed cells. Therefore, we reason that pMX-DsRed silencing
may provide a better definition of ‘‘mature reprogrammed’’ cells
than activation of the Oct4 gene, which has surprisingly been
shown to represent heterogeneously reprogrammed cells (Polo
et al., 2012).
Our RNAi screen may not have captured all possible modula-
tors of reprogramming, probably owing to several factors
including heterogeneity of virus transduction of shRNAs and
OSKM, insufficient knockdown of target genes, and other poten-
tial technical issues in this multiple-step screening process.
These limitations could be overcome by using newer algorithms
to design efficient shRNA libraries, CRISPR-Cas9 technologies,
and a homogeneous reprogramming system (polycistronic ex-
pression or somatic cells harboring inducible reprogramming
factors). Despite these caveats, we provide a proof of principle
that an unbiased pooled RNAi screen can be used to dissect
functional requirement inmultistepcomplexbiological pathways.Recently, it has been suggested that the non-differentially ex-
pressed genes or conserved pathways might play complex roles
contributing to tissue-specific functions or oncogenesis (Loca-
sale, 2013). Here, we vigorously tested the hypothesis that the
non-differentially expressed genes play important roles in direct-
ing cell-fate decisions. Our functional genomics approach shows
that in addition to tissue-specific genes, many non-differentially
expressed genes actually play important roles in cell-fate transi-
tion during reprogramming (Figure S6B). Thus, we suggest that
studies such as ours that use genome-wide RNAi screening to
define reprogramming mechanisms will have numerous applica-
tions in this field, such as providing novel approaches to small-
molecule targeting, cell-fate manipulation, and progenitor
derivation. More importantly, our work not only uncovers the
landscape of reprogramming, but also defines the cell-fate deter-
minants at each transition step of induced reprogramming. In
summary, our results provide a wealth of information about the
functional genetic requirements at various transition steps during
reprogramming and may lead to a paradigm shift in viewing the
functional significance of genomic infrastructure in biology.
EXPERIMENTAL PROCEDURES
Oct4-EGFP MEF Derivation
Oct4-EGFP MEFs were derived from the mouse strain B6;129S4-
Pou5f1tm2(EGFP)Jae/J (The Jackson Laboratory, stock no. 008214) with the
use of the protocol provided on the WiCell Research Institute website (http://
www.wicell.org/). In brief, embryonic day 13.5 embryos were collected from
time-mated pregnant female mice. Cells isolated from embryos were then
tested for microbial contamination. All animal work was approved by the
Sanford-Burnham institutional review board and was performed following
Institutional Animal Care and Use Committee guidelines. Oct4-EGFP MEFs
were maintained in MEF complete medium (Dulbecco’s modified Eagle’s
medium with 10% fetal bovine serum, nonessential amino acids, and L-gluta-
mine, without sodium pyruvate). Robustly growing cells (usually more than four
passages) were used for induced reprogramming.
FACS and Whole-Genome RNAi Screening
Cells were transduced with retroviruses containing pMXs-DsRed plasmids,
harvested 3 days later, and then stained with phycoerythrin-Cy7 (PE-Cy7)-
conjugated antibodies targeting Thy1 (25-0902, eBioscience). Thy1/DsRed
double-positive cells (Thy1+/DsRed+) were isolated by FACS and allowed to
recover 3 days before introduction of the shRNA library and OSKM. Pseudovi-
ruses expressing a pGIPz-shRNA library and pMXs-OSKM were generated in
293FT and Plate-E cells, respectively. Pseudoviruses were administered at
days 0 and 1 during reprogramming to maximize transduction efficiency.
ESC medium was used for culturing transformed cells at day 3 post induction.
Two weeks later, cells were harvested and dissociated with trypsin/EDTA. PE-
Cy7-conjugated antibodies targeting Thy1 (25-0902, eBioscience) and Alexa
Fluor 647-conjugated SSEA1 antibodies (51-8813, eBioscience) were used
to detect Thy1 and SSEA1 surface markers. Before isolating cells with FACS,
SSEA1+ cells were enriched using Anti-SSEA-1 (CD15) MicroBeads (130-
094-530, Miltenyi Biotec GmbH). SSEA1-enriched cells were used for sorting
SSEA1+/DsRed+ and SSEA1+/DsRed cell populations. SSEA1-depleted cells
were used for sorting Thy1+/SSEA1 and Thy1/SSEA1 cell populations.
shRNA-library screening in reprogramming was conducted independently
three times. Total RNAs and genomic DNAs were extracted from sorted
populations for mRNA microarray analysis and SOLiD sequencing analysis.
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